Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Nephritis”

Showing 20 of 0 results

Not applicableStudy completedNCT00793585
What this trial is testing

A Controlled Study of Uric Acid on the Progression of IgA Nephropathy

Who this might be right for
IgA Nephropathy
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Not applicableStudy completedNCT06589752
What this trial is testing

Replication of the NefIgArd Trial of TRF-budesonide in Primary IgAN

Who this might be right for
Primary IgA Nephropathy
Ruijin Hospital 200
Testing effectiveness (Phase 2)Study completedNCT02949349
What this trial is testing

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Genovate Biotechnology Co., Ltd., 32
Testing effectiveness (Phase 2)Ended earlyNCT04376827
What this trial is testing

Guselkumab in Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC 33
Early research (Phase 1)Looking for participantsNCT07266181
What this trial is testing

Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous Nephropathy

Who this might be right for
Refractory Membranous Nephropathy
The First Affiliated Hospital of Air Force Medicial University 5
Testing effectiveness (Phase 2)Study completedNCT00976300
What this trial is testing

Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Institute of Rheumatology, Prague 40
Large-scale testing (Phase 3)Ended earlyNCT03608033
What this trial is testing

Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Omeros Corporation 360
Testing effectiveness (Phase 2)WithdrawnNCT02433236
What this trial is testing

Open Label Study of Fostamatinib in the Treatment of IgA Nephropathy

Who this might be right for
IGA Nephropathy
Rigel Pharmaceuticals
Post-approval studies (Phase 4)UnknownNCT04145687
What this trial is testing

Metformin In Prevention of Lupus Nephritis

Who this might be right for
Lupus Nephritis
RenJi Hospital 30
Not applicableLooking for participantsNCT06926244
What this trial is testing

RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)

Who this might be right for
IgA Nephropathy (IgAN)
Assistance Publique - Hôpitaux de Paris 800
Not applicableStudy completedNCT01269021
What this trial is testing

An Multi-site Prospective Study to Assess the Efficacy and Safety of MMF in the Treatment of Proliferative IgA Nephropathy(IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Zhi-Hong Liu, M.D. 176
Early research (Phase 1)Ended earlyNCT01369628
What this trial is testing

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Who this might be right for
Lupus Nephritis
EMD Serono 1
Not applicableUnknownNCT04218890
What this trial is testing

TF, TFPI and Plasmin as Novel Bio-markers in Early Diagnosis of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 100
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Not applicableStudy completedNCT04522505
What this trial is testing

Long-term Follow-up for Evaluating the Safety of CS20AT04 in Subject with Lupus Nephritis

Who this might be right for
Lupus Nephritis
Corestemchemon, Inc. 6
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Testing effectiveness (Phase 2)WithdrawnNCT00390091
What this trial is testing

Study of LJP 394 (Abetimus Sodium) in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
La Jolla Pharmaceutical Company
Testing effectiveness (Phase 2)Ended earlyNCT04042623
What this trial is testing

Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy

Who this might be right for
IgA Nephropathy
Aravive, Inc. 1
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation